期刊文献+

甲状腺微小乳头状癌发生隐匿性颈部淋巴结转移的危险因素分析 被引量:1

Analysis of the Risk Factors of Occult Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma
原文传递
导出
摘要 目的:分析甲状腺微小乳头状癌(PTMC)发生隐匿性颈部淋巴结转移的危险因素。方法:收集2013-2017年于青岛大学附属医院确诊的PTMC患者共1524例,按其术前、术后是否有颈部淋巴结转移分为显性淋巴结转移、隐匿性淋巴结转移及无淋巴结转移三组,比较各组之间的临床病理特征,包括性别(男性)、年龄、肿瘤大小、双叶、多灶、侵犯包膜、合并桥本病、术前TSH水平等是否具有差异性。结果:单因素分析结果显示:与无淋巴结转移患者相比,隐匿性淋巴结转移组男性患者比例、年龄、肿瘤大小、肿瘤累及双叶、多灶比例均有统计学差异(P<0.05),其中隐匿性淋巴结转移组中的发病年龄较低(P<0.05),合并桥本病的比率无显著差异(P>0.05);与显性淋巴结转移相比,隐匿性淋巴结转移肿瘤大小、合并多灶及合并病理桥本病的转移率较后者低(P<0.05)。多因素分析表明以无淋巴结转移的患者为对照组,男性患者、年龄、大小、多灶为隐匿性淋巴结转移的危险因素(OR值分别为0.525,1.033,0.169,0.562);与隐匿性淋巴结转移相比,合并桥本病的患者发生显性颈部淋巴结转移的风险更高,而发病年龄较前者大(OR值分别为0.370,0.979)。结论:男性、肿瘤累及双叶、多灶者为PTMC早期淋巴结转移的危险因素,合并桥本病者发生显性颈部淋巴结转移的风险更高;但没有发现桥本病与隐匿性颈部淋巴结转移存在相关性。 Objective: To investigate the risk factors of occult cervical lymph node metastasis in papillary thyroid microcarcinoma.Methods: The clinical records of 1524 cases of PTMC patients diagnosed in the Affiliated Hospital of Qingdao University from 2013 to2017 were reviewed.The pathological and clinical characteristics were analyzed of dominant lymph node metastasis,occult lymph node metastasis and patients without lymph node metastasis,including gender(male),age,number of lesions,capsular invasion and Hashimoto's disease.Results: In the univariate analysis,patients without lymph node metastasis,age,tumor with double blade,multifocality had statistic difference(P〈0.05).And the age of the occult lymph node metastasis group is lower(P〈0.05),there was no significant difference in the ratio of Hashimoto's disease(P〉0.05).Compared with dominant lymph node metastases,patients with occult lymph node metastasis had lower tumor size,multifocality and the pathological Hashimoto's disease(P〈0.05).Multivariate analysis showed that gender,age,tumor size and multifocality were risk factors for occult lymph node metastasis(OR=0.525,1.033,0.169,0.562).Compared with the occult lymph node metastasis,patients with Hashimoto's disease had a higher risk of dominant cervical lymph node metastasis,and the age of onset was larger than that of the former(OR=0.370,0.979).Conclusion: The risk factors for early lymph node metastasis of PTMC were male,tumor involving double lobe S and multifocality.The risk of dominant cervical lymph node metastasis was higher in patients with Hashimoto's disease,but there was no correlation between Hashimoto's disease and occult cervical lymph node metastasis.
作者 蒋倩楠 王斐 王萍 赵慧 迟静薇 赵世华 JIANG Qian-nan;WANG Fei;WANG Ping;ZHAO Hui;CHI Jing-wei;ZHAO Shi-hua(The Affiliated Hospital of Qingdao University,Department of Endocrinology and Metabolism,Qingdao,Shandong,266555,China;Hiser medical center of Qingdao,Department of Endoctinology,Qingdao,Shandong,266033,China;The Affiliated Hospital of Qingdao University,Laboratory of thyroid,Qingdao,Shandong,266555,China)
出处 《现代生物医学进展》 CAS 2018年第10期1977-1981,1995,共6页 Progress in Modern Biomedicine
基金 山东省中青年科学家科研奖励基金项目(BS2009YY030) 青岛市民生计划项目(13-1-3-58-nsh)
关键词 甲状腺微小乳头状癌 颈部淋巴结转移 危险因素 Papillary thyroid microcarcinoma Lymph node metastasis Risk factors
  • 相关文献

参考文献3

二级参考文献27

  • 1盖宝东,郑泽霖,张德恒,王树地.169例结节性甲状腺肿与甲状腺癌并存的诊治体会[J].中国普外基础与临床杂志,2004,11(6):496-497. 被引量:24
  • 2吴延升,张仑,王旭东,张文超.甲状腺乳头状癌预后多因素分析[J].中国肿瘤临床,2007,34(22):1294-1297. 被引量:34
  • 3HEDINGER C E, WILLIAMS E D, SOBIN L H. Histologicaltyping of thyroidtumours[M]. NewYork: Springer-Verlag,1988: 9.
  • 4KIM H Y, PARK W Y, LEE K E, et al. Comparative analysisof gene expression profiles of papillary thyroid microcarcinomaand papillary thyroid carcinoma [J]. Cancer Res Ther,2010, 6(4): 452-457.
  • 5HARACH H R, FRANSSI LA K O, WASENIUS V M. Occult papillary carcinoma of the thyroid. A “normal” finding inFinland. A systematic autopsy study [J]. Cancer, 1985,56(3): 531-538.
  • 6L I N J D . I n c r e a s e d i n c i d e n c e o f p a p i l l a r y t h y r o i dmicrocarcinoma with decreased tumor size of thyroid cancer[J]. Med Oncol, 2010, 27(2): 510-518.
  • 7KIM D W, KIM S H, JUNG S J. Successful sonographyguidedfine-needle aspiration biopsy of a 1-millimeterdiameterpapillary thyroid microcarcinoma[J]. AJNR Am JNeuroradiol, 2010, 31(6): 1082-1084.
  • 8ROH J L, KIM J M, PARK C I. Central compartmentreoperation for recurrent/persistent differentiated thyroidcancer: patterns of recurrence, morbidity, and prediction ofpostoperative hypocalcemia[J]. Ann Surg Oncol, 2011,18(5): 1312-1318.
  • 9ITO Y, MIYAUCHI A, INOUE H, et al. An observational trialfor papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1): 28-35.
  • 10LIM Y C, CHOI E C, YOON Y H, et al. Central lymph nodemetastases in unilateral papillary thyroid microcarcinoma[J]. Br J Surg, 2009, 96(3): 253-257.

共引文献31

同被引文献10

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部